The Legal Tensions of Collaboration and Competition in the Life Sciences Industry

Share!

Insurance Journal - Sep 20, 2023

Moderna’s suit against Pfizer and partner BioNtech over alleged COVID-vaccine-related patent infringement – and the targets’ countersuit – might suggest an abrupt return to business as usual after an unprecedented period of cooperation among life sciences companies during the height &#82...

Read Full Article

Recommended Articles

Expert Underwriter Secures Critical Wildfire Coverage for High-Risk California Warehouse, Saving Key Account

Posted: Oct 30, 2025

Monrovia, CA ., Oct 30, 2025 – In a notable victory against challenging market conditions, the speci...

GM to Cut EV, Battery Production and 1,200 jobs at Michigan Plant

Posted: Oct 30, 2025

General Motors GM.N said on Wednesday it will cut U.S. electric vehicle and battery production and 1...

WTW Reports Flat Q3 Revenue of $2.29 Billion, With Organic Growth of 5%

Posted: Oct 30, 2025

WTW reported third quarter revenue of $2.29 billion, flat with $2.29 billion for Q3 2024, which the...